-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Downgrades Bio-Techne to In-Line, Lowers Price Target to $62

Benzinga·01/05/2026 18:02:57
語音播報
Evercore ISI Group analyst Daniel Markowitz downgrades Bio-Techne (NASDAQ:TECH) from Outperform to In-Line and lowers the price target from $68 to $62.